Description
(Text)
This book, in its 2nd edition, is a collection of cases with challenging diagnosis, in which nuclear medicine examinations have been particularly helpful for the clinicians to perform the final diagnosis or to follow-up the patient. The cases selected are primarily in patients with neurodegenerative disorders, epilepsy and brain tumors. Authors have been selected from internationally recognized experts in the field of Neuroimaging in neurology. All authors have large experience as clinicians and as teachers within the Nuclear Medicine community.
The volume includes cases related to emerging topics such as theranostics for brain tumors and new emerging scenarios for brain PET imaging in the era of Alzheimer's disease modifying drugs.
The book is intended for nuclear medicine specialists as well as clinicians to provide guidance in the interpretation of neurology cases in the clinical settings, particularly with regards to correct approach to the interpretation ofdiagnostic imaging procedures.
(Author portrait)
Andrea Varrone is Professor of Molecular PET at Karolinska Institutet. Andrea Varrone is a Nuclear Medicine physician with a PhD in Functional radioisotopic imaging. He is Head of the Division of Imaging Core Facilities at the Department of Clinical Neuroscience at Karolinska Institutet and Scientific Director of the Core Facilities Autoradiography, Radiopharmacy, and Brain Molecular Imaging Centre. Prof. Varrone is Research Group Leader for Molecular Imaging in Neurodegenerative Disorders with special focus on the study of patients with movement disorders and he is an expert in Translational PET imaging.
Silvia Morbelli is Full Professor of Nuclear Medicine at the University of Turin and Director of the Nuclear Medicine service of AOU Città della Salute e della Scienza di Torino. She has a PhD in Applied Neurosciences and she made contributions related to the use of neuroimaging tools as diagnostic and prognostic biomarkers in the earliest and preclinical stages of Neurodegenerative Dementia and Parkinsonian Syndromes.
Valentina Garibotto is Director of the Division of Nuclear Medicine and Molecular Imaging at the Geneva University Hospitals and Professor and Director pf the Department of Radiology and Medical Informatics at the Geneva University. Prof. Garibotto has a large clinical expertise in molecular imaging and coordinates multiple clinical trials on the validation of novel PET tracers, namely for the diagnostic assessment and physiopathological investigation of cognitive disturbances.
